General Announcement::Successful closure of the decentralised registration procedure (DCP) for generic Seretide Accuhaler

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Dec-2017 13:55:59
Status
New
Announcement Sub Title
Successful closure of the decentralised registration procedure (DCP) for generic Seretide Accuhaler
Announcement Reference
SG171201OTHRXCBF
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
01/12/2017 11:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Glenmark announces successful closure of the decentralised registration procedure (DCP) for generic Seretide Accuhaler in the Nordic region.

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.


Attachments

PR_01122017.pdf
Total size =537K